MedBridge to Release Powerful Patient Relationship Management Platform

Reach New Patients, Retain Current Patients, and Build Relationships for Life with MedBridge Connect

News provided by

Nov 03, 2016, 09:37 ET

SEATTLE, Nov. 3, 2016 /PRNewswire/ -- MedBridge, an industry leader in patient engagement and continuing education, announced the December Beta release of MedBridge Connect, a comprehensive patient relationship management platform designed to improve patient acquisition, retention, and referrals.

Logo - http://photos.prnewswire.com/prnh/20161103/436127LOGO

Integrated with MedBridge's current enterprise solution, MedBridge Connect will allow effortless, individualized outreach, including patient check-ins, reminders, and reporting. Specific benefits include increased lead generation, reduced rates of self-discharge, boosted social media ratings, and enhanced patient satisfaction.

Campaigns are easily scheduled to match patient needs and optimize retention. MedBridge Connect is unique with its extensive library of interactive and captivating content and campaigns. Clients may choose from MedBridge-provided content or build their own, all branded with the institution's logo.

"Improved outcomes begin with taking care of the patient at all points of the continuum of care," said MedBridge Founder & CEO, Justin Kowalchuk. "MedBridge is excited about launching our upcoming patient marketing solution and to see our clients leading the charge toward a patient-centered health experience."

MedBridge Connect is currently in beta testing with select clients. A few spaces are still open; organizations who would like to participate are encouraged to contact MedBridge. General release of Connect is targeted for First Quarter, 2017.

For more information or to request a demo, please visit MedBridge Patient Relationship Management.

Related Links

MedBridge for Enterprise

MedBridge Newsroom

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

SOURCE MedBridge